Explore more publications!
Maryland Healthcare Reporter
Got News to Share?

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 10, 2025

Global Wound Dressings Market Set to Reach USD 15.87 Billion by 2030 | MarketsandMarkets™
November 10, 2025

Global Wound Dressings Market Set to Reach USD 15.87 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
New Academy of Nutrition and Dietetics Position Paper Reinforces the Power of Medical Nutrition Therapy in Chronic Disease Care
November 10, 2025

New Academy of Nutrition and Dietetics Position Paper Reinforces the Power of Medical Nutrition Therapy in Chronic Disease Care

Indeterminate GlobeNewswire
Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics
November 10, 2025

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

Indeterminate GlobeNewswire
Olympia Pharmaceuticals Launches OlympiaGO: A Convenient Hydration Drink Mix for Immune Support and Wellness
November 10, 2025

Olympia Pharmaceuticals Launches OlympiaGO: A Convenient Hydration Drink Mix for Immune Support and Wellness

Indeterminate GlobeNewswire
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
November 10, 2025

JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025

Indeterminate GlobeNewswire
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
November 10, 2025

IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026

Indeterminate GlobeNewswire
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025

Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Codexis Announces Signing of Lease for GMP Manufacturing Facility
November 10, 2025

Codexis Announces Signing of Lease for GMP Manufacturing Facility

Indeterminate GlobeNewswire
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
November 10, 2025

Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe

Indeterminate GlobeNewswire
Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
November 10, 2025

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

Indeterminate GlobeNewswire
TOMI Environmental Solutions to Showcase Decontamination Innovations at AALAS 76th National Meeting
November 10, 2025

TOMI Environmental Solutions to Showcase Decontamination Innovations at AALAS 76th National Meeting

Indeterminate GlobeNewswire
AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer
November 10, 2025

AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer

Indeterminate GlobeNewswire
Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline
November 10, 2025

Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company’s R&D Pipeline

Indeterminate GlobeNewswire
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
November 10, 2025

Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials

Indeterminate GlobeNewswire
24/7 Market News- Kraig Labs Emerges as Spider Silk Trailblazer
November 10, 2025

24/7 Market News- Kraig Labs Emerges as Spider Silk Trailblazer

Indeterminate GlobeNewswire
Vatica Health earns consistent high performer award 
November 10, 2025

Vatica Health earns consistent high performer award 

Indeterminate GlobeNewswire
Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025
November 10, 2025

Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025

Indeterminate GlobeNewswire
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors
November 10, 2025

Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors

Indeterminate GlobeNewswire
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
November 10, 2025

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

Indeterminate GlobeNewswire
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
November 10, 2025

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions